133
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Biomarkers of leukocyte traffic and activation in the vaginal mucosa

, , , , &
Pages 608-622 | Received 23 Apr 2007, Published online: 08 Oct 2008

References

  • Ahmad M, Theofanidis P, Medford RM. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. Journal of Biological Chemistry 1998; 273: 4616–4621
  • Alfano M, Poli G. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Molecular Immunology 2005; 42: 161–182
  • Blann AD, Herrick A, Jayson MI. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. British Journal of Rheumatology 1995; 34: 814–819
  • Carlos TM, Harlan JM. Leukocyte–endothelial adhesion molecules. Blood 1994; 84: 2068–2101
  • Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. Biomedical Pharmacotherapy 2005; 59: 430–437
  • Coleman N, Stanley MA. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer 1994; 74: 884–892
  • Collins T, Read M, Neish A, Whitley M, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB Journal 1995; 9: 899–909
  • Cone RA, Hoen T, Wong X, Abusuwwa R, Anderson DJ, Moench TR. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infectious Diseases 2006; 6: 90
  • Cummins JE, Jr, Guarner J, Flowers L, Guenthner PC, Bartlett J, Morken T, Grohskopf LA, Paxton L, Dezzutti CS. Preclinical testing of candidate topical microbicides for anti-HIV-1 activity and tissue toxicity in a human cervical explant culture. Antimicrobial Agents and Chemotherapy 2007; 51: 1770–1779
  • Dhawan D, Mayer KH. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. Journal of Infectious Diseases 2006; 193: 36–44
  • Doncel GF, Chandra N, Fichorova RN. Preclinical assessment of the proinflammatory potential of microbicide candidates. Journal of Acquired Immune Deficiency Syndrome 2004; 37(Suppl. 3)S174–S180
  • Eckstein P, Jackson MCN, Millman N, Sobrero AJ. Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. Journal of Reproductive Fertility 1969; 20: 85–93
  • Fichorova RN, Desai PJ, Gibson F, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infection and Immunity 2001a; 69: 5840–5848
  • Fichorova RN, Tucker L, Anderson DJ. The molecular basis of nonoxynol-9 induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. Journal of Infectious Diseases 2001b; 184: 418–428
  • Fichorova RN, Cronin A, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of TLR-4-mediated signaling. Journal of Immunology 2002; 168: 2424–2432
  • Fichorova RN. Guiding the vaginal microbicide trials with biomarkers of inflammation. Journal of Acquired Immune Deficiency Syndrome 2004; 35: S1–S8
  • Fichorova RN, Bajpai M, Chandra N, Hsiu JG, Spangler M, Ratnam V, Doncel GF. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biological Reproduction 2004; 71: 761–769
  • Fichorova RN, Zhou F, Ratnam V, Atanassova V, Jiang S, Strick N, Neurath AR. Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation. Antimicrobial Agents and Chemotherapy 2005; 49: 323–335
  • Fletcher PS, Wallace GS, Mesquita PM, Shattock RJ. Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 2006; 3: 46
  • Foster JR. The functions of cytokines and their uses in toxicology. International Journal of Experimental Pathology 2001; 82: 171–192
  • Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacology & Therapeutics 2003; 100: 171–194
  • Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. Journal of Infectious Disease 2007; 195: 1332–1339
  • Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, Whitehead RH, Dempsey PJ, Raines EW. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). Journal of Biological Chemistry 2003; 278: 37459–37464
  • Hillier SL, Moench T, Shattock R, Black R, Reichelderfer P, Veronese F. In vitro and in vivo: the story of nonoxynol 9. Journal of Acquired Immune Deficiency Syndrome 2005; 39: 1–8
  • Howett MK, Kuhl JP. Microbicides for prevention of transmission of sexually transmitted diseases. Current Pharmaceutical Design 2005; 11: 3731–3746
  • Johansson EL, Rudin A, Wassen L, Holmgren J. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999; 96: 272–277
  • Kitani A, Nakashima N, Izumihara T, Inagaki M, Baoui X, Yu S, Matsuda T, Matsuyama T. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. Journal of Immunology 1998; 161: 4931–4938
  • Klebanoff SJ. Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 2005; 77: 598–625
  • Krebs FC, Miller SR, Catalone BJ, Fichorova R, Anderson D, Malamud D, Howett MK, Wigdahl B. Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate. Antimicrobial Agents and Chemotherapy 2002; 46: 2292–2298
  • Lard-Whiteford SL, Matecka D, O'Rear JJ, Yuen IS, Litterst C, Reichelderfer P. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. Journal of Acquired Immune Deficiency Syndrome 2004; 36: 541–552
  • Lawn SD, Subbarao S, Wright TC, Jr, Evans-Strickfaden T, Ellerbrock TV, Lennox JL, Butera ST, Hart CE. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. Journal of Infectious Disease 2000; 181: 1950–1956
  • Lee DK, Kang JE, Park HJ, Kim MH, Yim TH, Kim JM, Heo MK, Kim KY, Kwon HJ, Hur MW. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. Journal of Biological Chemistry 2005; 280: 27783–27791
  • Lichtenwalner AB, Patton DL, Klebanoff SJ, Headley CM, Hillier SL. Vaginal myeloperoxidase and flora in the pig-tailed macaque. Journal of Medical Primatology 2000; 29: 36–41
  • Littler A, Buckley C, Wordsworth P, Collins I, Martinson J, Simmons D. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Rheumatology 1997; 36: 164–169
  • Mansoor MA, Seljeflot I, Arnesen H, Knudsen A, Bates CJ, Mishra G, Larsen TW. Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clinical Biochemistry 2004; 37: 408–414
  • Matsuda M, Tsukada N, Miyagi K, Yanagisawa N. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy. Journal of Neuroimmunology 1995; 59: 35–40
  • McGowan I. Microbicides: a new frontier in HIV prevention. Biologicals 2006; 34: 241–255
  • Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y. Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clinical and Experimental Rheumatology 2002; 20: 403–406
  • O'Neil LA, Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects and plants. Journal of Leukocyte Biology 1998; 63: 650–657
  • Phillips DM, Maguire RA. The development of microbicides for clinical use to prevent sexually transmitted diseases. Current Infectious Disease Reports 2002; 4: 135–140
  • Quinn TC. Association of sexually transmitted diseases and infection with the human immunodeficiency virus: biological cofactors and markers of behavioral interventions. International Journal of STD & AIDS 1996; 7(Suppl. 2)17–24
  • Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nature Reviews. Immunology 2005; 5: 760–771
  • Segura RM, Alegre J, Varela E, Marti R, Surinach JM, Jufresa J, Armadans L, Pascual C, Fernandez de Sevilla T. Interleukin-8 and markers of neutrophil degranulation in pleural effusions. American Journal of Respiratory & Critical Care Medicine 1998; 157: 1565–1572
  • Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nature Reviews. Microbiology 2003; 1: 25–34
  • Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368: 489–504
  • Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nature Reviews. Drug Discovery 2002; 1: 977–985
  • Sugawara T, Gallucci RM, Simeonova PP, Luster MI. Regulation and role of interleukin 6 in wounded human epithelial keratinocytes. Cytokine 2001; 15: 328–336
  • Triantafilou M, Triantafilou K. The dynamics of LPS recognition: complex orchestration of multiple receptors. Journal of Endotoxin Research 2005; 11: 5–11
  • Trifonova RT, Pasicznyk JM, Fichorova RN. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo. Antimicrobial Agents and Chemotherapy 2006; 50: 4005–4010
  • Van den Brink GR, ten Kate FJ, Ponsioen CY, Rive MM, Tytgat GN, van Deventer SJH, Peppelenbosch MP. Expression and activation of NF-κB in the antrum of the human stomach. Journal of Immunology 2000; 164: 3353–3359
  • Xyni K, Rizos D, Giannaki G, Sarandakou A, Phocas I, Creatsas G. Soluble form of ICAM-1, VCAM-1, E- and L-selectin in human milk. Mediators of Inflammation 2000; 9: 133–140

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.